跳至主要内容
临床试验/NCT04131920
NCT04131920已完成不适用

Handheld Ultrasound (HHUS) for Home Use in Hemophilia

Washington Institute for Coagulation1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Outcome 2.2: Accuracy of the assignment of "bleed" vs. "non-bleed" will be determined on the stationary GE LS8 Logiq Pro in the HTC.

研究概览

简要总结

This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a bleed or not.

详细描述

This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a bleed or not.

Phase 1 will assess whether 10 subjects with severe hemophilia A can be trained to use HHUS in clinic to identify basic joint structures of the elbow, knee and ankle. It will then assess whether these subjects can identify these structures at home and transmit the images life via tele-ultrasound.

Phase 2 will assess whether the determination of "bleed" vs. "non-bleed" made at home via HHUS can be confirmed/validated with a standard high resolution ultrasound machine in clinic.

Phase 3 will then utilize HHUS during the EmiMSKUS study over 3 years to more objectively identify patient reported bleeding during the study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Severe hemophilia A
  • Over 18 years of age
  • Able to read, write and understand English
  • Willing to come to the center for an 8 hour training session
  • Lives in proximity of the HTC and is willing to come in for acute joint episodes in phase 2
  • Willing and able to follow study procedures
  • Willing and able to keep HHUS at a safe place
  • Have the dexterity to operate a HHUS unit

排除标准

  • Unable to follow study instructions
  • Physically or mentally unable to operate a HHUS unit

结局指标

主要结局

Outcome 2.2: Accuracy of the assignment of "bleed" vs. "non-bleed" will be determined on the stationary GE LS8 Logiq Pro in the HTC.

时间窗: 6 months

Percentage accuracy of the assignment of "bleed" vs. "non-bleed" will be determined on the stationary GE LS8 Logiq Pro in the HTC.

Outcome 3.1: To establish how accurate patient reported bleeding is compared to HHUS utilizing tele-ultrasound.

时间窗: 3 years

Percentage accuracy of patient reported bleeding is compared to HHUS utilizing tele-ultrasound.

Outcome 1.1: Participant understanding of basic ultrasound transducer concepts and ability to perform basic positioning maneuvers.

时间窗: 3 months

Number of participating subjects who understand basic ultrasound transducer concepts and can perform basic positioning maneuvers based on post-training test.

Outcome 1.3: Participating subjects can perform what they learned during their training at the HTC in outcome 1.1 and outcome 1.2 at home and transmit images to the HTC.

时间窗: 3 months

Number of participating subjects who can perform what they learned during their training at the HTC in outcome 1.1 and outcome 1.2 at home and transmit images to the HTC on post-training test.

Outcome 3.2: To establish more accurate bleeding data for the EmiMSKUS study.

时间窗: 3 years

Number of patients who have joint bleeding data incorporated into the EmiMSKUS study.

Outcome 1.2: Participating subjects are able to perform basic transducer positions and identify basic structures of the elbow, knee and ankle.

时间窗: 3 months

Number of participating subjects who are able to perform basic transducer positions and identify basic structures of the elbow, knee and ankle based on post-training test.

Outcome 2.1: Subjects will be able to attain and transmit images of their joint spaces to the HTC via telemedicine utilizing the HHUS technology they learned in phase 1 and React App.

时间窗: 6 months

Number of subjects who will be able to attain and transmit images of their joint spaces to the HTC via telemedicine utilizing the HHUS technology they learned in phase 1 and React App.

次要结局

未报告次要终点

研究者

发起方
Washington Institute for Coagulation
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rebecca Kruse-Jarres, MD, MPH

Executive/Medical Director, Washington Center for Bleeding Disorders

Washington Institute for Coagulation

研究点 (1)

Loading locations...

相似试验